Anti-VEGF antibody therapy (INSERM)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAnti-VEGF antibody therapy (INSERM)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsOcular inflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInstitut National De La Sante Et De La Recherche Medicale
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInstitut National De La Sante Et De La Recherche Medicale
Active IndicationsN/A
Inactive IndicationsOcular inflammation

Other Information

ATC CodeN/A
Related LinksN/A